- Home
- CM vs ZTS Comparison
CM vs ZTS Comparison
Compare CM & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CM
- ZTS
- Stock Information
- Founded
- CM 1867
- ZTS 1952
- Country
- CM Canada
- ZTS United States
- Employees
- CM N/A
- ZTS N/A
- Industry
- CM
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- CM
- ZTS Health Care
- Exchange
- CM Nasdaq
- ZTS Nasdaq
- Market Cap
- CM 63.2B
- ZTS 69.3B
- IPO Year
- CM N/A
- ZTS 2013
- Fundamental
- Price
- CM $78.30
- ZTS $153.32
- Analyst Decision
- CM Buy
- ZTS Buy
- Analyst Count
- CM 2
- ZTS 7
- Target Price
- CM $107.50
- ZTS $201.71
- AVG Volume (30 Days)
- CM 1.3M
- ZTS 2.4M
- Earning Date
- CM 08-28-2025
- ZTS 11-03-2025
- Dividend Yield
- CM 3.49%
- ZTS 1.31%
- EPS Growth
- CM 19.51
- ZTS 14.10
- EPS
- CM 5.97
- ZTS 5.82
- Revenue
- CM $18,799,812,132.00
- ZTS $9,385,000,000.00
- Revenue This Year
- CM $23.26
- ZTS $3.90
- Revenue Next Year
- CM $2.98
- ZTS $6.00
- P/E Ratio
- CM $13.10
- ZTS $26.22
- Revenue Growth
- CM 14.55
- ZTS 5.27
- 52 Week Low
- CM $53.62
- ZTS $139.70
- 52 Week High
- CM $79.67
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- CM 73.09
- ZTS 49.60
- Support Level
- CM $76.10
- ZTS $151.35
- Resistance Level
- CM $77.73
- ZTS $156.49
- Average True Range (ATR)
- CM 1.14
- ZTS 2.64
- MACD
- CM 0.49
- ZTS -0.11
- Stochastic Oscillator
- CM 80.68
- ZTS 21.58
About CM Canadian Imperial Bank of Commerce
Canadian Imperial Bank of Commerce is Canada's fifth-largest bank with around CAD 1 trillion in assets. It operates four business segments: Canadian retail and business banking, Canadian commercial banking and wealth management, US commercial banking and wealth management, and capital markets. It serves approximately 14 million personal banking and business customers, primarily in Canada and the US.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.